Brian Poligone

Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial

Youn H. Kim, M. Bagot, Lauren Pinter‐Brown et al. · The Lancet Oncology · 2018 · 621 citations · Full text

Cutaneous T-cell Lymphoma, Lymphoid Neoplasia, Medicine +6

Positive and Negative Regulation of NF-κB by COX-2

Brian Poligone, Albert S. Baldwin · Journal of Biological Chemistry · 2001 · 256 citations · Full text

Elevated NF-κB Activation in Nonobese Diabetic Mouse Dendritic Cells Results in Enhanced APC Function

Brian Poligone, Donald J. Weaver, Pradip Sen et al. · The Journal of Immunology · 2002 · 157 citations

Dendritic Cells from Nonobese Diabetic Mice Exhibit a Defect in NF-κB Regulation Due to a Hyperactive IκB Kinase

Donald J. Weaver, Brian Poligone, Thi Tho Bui et al. · The Journal of Immunology · 2001 · 125 citations · Full text

NF-κB Hyperactivation Has Differential Effects on the APC Function of Nonobese Diabetic Mouse Macrophages

Pradip Sen, Sandip Bhattacharyya, Mark A. Wallet et al. · The Journal of Immunology · 2003 · 70 citations · Full text